New Aspects of Breast Cancer Vol. 2. Risk Factors in Breast Cancer by Cole, M. P.
BOOK REVIEWS 457
known autlhorities ill the field of childhood
malignancy, in the United States, and write
authoritatively on their subjects.
The book opens with three chapters listed
as current commentary. The first, by Bur-
chenal, indicates the progress that has been
made in the last 30 years in the improvements
in cures, by the development of multi-
disciplinary therapy in many childhood
cancers. Mauer, in the second commentary,
makes the case for special centres for treat-
ment and research-but always in co-opera-
tion with referring physicians. The third
commentary, by Vaeth, draws attention to
the need for radiotherapy to be used carefully
and judiciously, so that the unwNanted
effects on normal tissues can be kept to a
ininimum.
The remaining chapters deal with in-
dividual malignancies, such as the acute
leukaemias or Wilms', in more detail, and
describe their up-to-date management. All
are very well written and are a good guide to
the subjects concerned. Unfortunately, in a
few cases, events have overtaken the recom-
nended management, which has changed to
varying extents since the book w%as written,
but in this rapidly changing field this is only
to be expected.
I found all the chapters on the different
tumours very informative, about both diag-
nosis and management, except the one on
neuroblastoma which, whilst full ofinteresting
facts about this tumour, did not really give
any guidance on the management of children
with neuroblastoma.
The chapters oninfection, immunotherapy
and chemotherapy were also, I thought,
excellent, and will provide for manv clinicians
a good reference on these subjects in the
paediatric oncology field.
The final chapter deals with the group
approach to the support of parents, children
and staff, and is certainly one way of dealing
with the psychological and emotional prob-
lems encountered during the management of
children with malignant disease. I think this
is a more American approach (perhaps in
Britain a looser grouping occurs) but it is an
interesting approach.
I think this is a book of quality about
cancer in children, and it is just as useful to
the specialist, of whatever modality, in the
teams treating children with cancer, as it is to
the general paediatrician.
D. PEARSON
New Aspects of Breast Cancer Vol. 2.
Risk Factors in Breast Cancer. Ed.
BASIL STOLL (1976). London: William
Heinemann Medical Books Ltd. 269 pp.
Price £5.00 net.
In the preface to this volume, the Editor
defines the two specific groups of patients at
risk from breast cancer, the management of
whom is the subject of this book. They are
(1) women with an increased predisposition
to the development of breast cancer and (2)
women wiith breast cancer whose disease
carries a relatively poor prognosis.
An international group of wrriters con-
tributes to the 16 chapters, which aregrouped
into 3 parts: (1) Women at Risk; (2) Prognos-
tic Factors; (3) Selective Screening.
In the first part, on Women at Risk,
contributors give extensive references from
world literature supporting or refuting widely
held viewrs as to risk factors, such asheredity,
environment, endocrine factors etc., also the
malignant potential of presumed simple
breast conditions is discussed. Naturally, it
has not always been possible to reach a
definite conclusion, but only to present the
reader with a balaneed assessment of the
situation.
The section on Prognostic Factors con-
siders not only the prognosis in relation to
histopathology, age of onset of the disease,
endogenous hormones, pregnancy and lacta-
tion, but also the psychosomatic factors and
their possible effect on tumour growth,
suggesting that women who present with
advanced disease or w%Nho recur wAithin 12
months of treatment include the highest
proportion of those who required medication
for emotional distress in the past. With
regard to the pregnant patient, it is suggested
that if the cancer is early and slow growing,
and the woman is in the second half of her
pregnancy, it may be reasonable to delay
treatment of the cancer until after delivery:
advice that might not be universally accept-
able. The place of urinary hormone excre-
tion studies as a means of predicting possible
response of patients to adrenalectomy or
hypophysectomy is discussed; also the limita-
tions of those studies.
The section on Selective Screening reviews
the possible methods and results of screening
both for primary and secondary cancer, but
in addition recognizes the financial implica-
tion of widespread attempts to define a458 BOOK REVIEWS
selected group at high risk who should be
screened.
The book provides a very compact
description ofthe many factors of importance
both in the development of breast cancer and
in its prognosis. With its extensive list of
references, it will be of value to workers in
this field.
M. P. COLE
Hodgkin'sDisease.Ed.MORTIMERJ.LACHER
(1976). New York: John Wiley & Sons.
429 pp. Price £14.00 net.
The management of patients with Hodg-
kin's disease has changed a great deal over
the last decade, with the introduction of
staging laparotomies, improved radiotherapy
techniques and effective combination chemo-
therapy. This book aims, in a series of
chapters written by a variety of American
authorities, to bring together the vast
literature thathasaccumulated recently about
this rare disease. It divides conveniently
into three main sections: staging, treatment
and complications of Hodgkin's disease.
The chapters onthe accurate staging ofthe
disease are informative and well illustrated.
The indications and surgical technique
for staging laparotomy and splenectomy
are covered in detail. Dr Lacher finishes the
section by hoping that in the not so distant
future the laparotomy/splenectomy procedure
" will eventually be recalled only as a mile-
stone in the history of Hodgkin's disease and
management, important at the time, but
abandoned because it was no longer needed ".
The section on treatment is not as clear
and informative as the other parts ofthebook.
The radiotherapy techniques employed at the
Memorial Hospital are described in detail, but
these are new techniques with few results.
A book ofthis nature requires an authoritative
review chapter on the use of radiotherapy in
Hodgkin's disease, with long-term results of
various techniques and doses. The chemo-
therapy section overlaps in a number of
chapters, and is based mainly on American
results. British oncologists will be dis-
appointed to see the results of the MVPP
regime (introduced by the late Professor G. H.
Fairley) reported as giving only a 420
complete remission rate, approximately half
of the actual remission rate.
The chapters on neurological complica-
tions, infections, respiratoryfailureandgastro-
intestinal manifestations are all comprehen-
sive and valuable reading. A short chapter
on the use of Indomethacin for controlling
fever in Hodgkin's disease is an added bonus,
as is the chapter on "Clinical Vignettes" from
Dr Lacher's wide experience.
There is much to interest any doctor who
comes into contact with patients suffering
from Hodgkin's disease, whether he be
surgeon, radiotherapist, chemotherapist,
general practitioner or physician. It joins
the books on the subject edited by Kaplin
and Smithers as compulsory reading for any
doctor specializing in the management of
Hodgkin's disease.
J. H. SCARFFE
Unclassifiable Leukaemias. Proceedings
of a Symposium, October 11-13th 1974 at
the Institute of Cell Pathology, Hopital
de Bicetre, Paris. Ed. M. BESSIS and
G. BRECHER (1976). Berlin: Springer-
Verlag. 270 pp. Price $19.70 net.
Any haematologist who deals with leukae-
mic material knows that a significant
minority of patients with clinically " acute "
disease have blood and marrow pictures
which are not readily classifiable by morpho-
logical criteria alone. This symposium, to
which many distinguished clinical and experi-
mental workers contributed, was an attempt
to correlate " empirical " cytology and cyto-
chemical methods with other characteristics
of the leukaemic cell, such as immunological
markers, cytogenetics, electron microscopy,
cultural patterns and cell kinetics.
The book opens with an account of the
undoubted limits ofthe present morphological
classification ofacute leukaemias by Flandrin
and Bernard wNho nevertheless, surprisingly,
found that only 2%0o of 1409 cases seen in their
clinic were eventually labelled " undifferenti-
ated leukaemia ". Galton and Dacie give a
detailed analysis of material admitted to the
4th and 5th MRC trials on acute myeloblastic
leukaemia. Some British haematologists
have found it difficult to comprehend the sub-
classification ofALL given by Mathe, though
most now recognise the microlymphoblastic
and immunoblastic types; it is interesting
that this classification includes prolympho-
cytic leukaemia as a variant of ALL and not
CLL, as is sometimes assumed.